EUVIMEDEUVIMED entdecken
Crossref

Rituximab in Severe Mucocutaneous Pemphigus Vulgaris Complicated by Sepsis: a Difficult Path to Disease Control

Anna Wojas-Pelc, Mirella Brzozowska, Arletta Kozłowska, Przemysław Hałubiec, Bartosz Obtułowicz, Andrzej K. Jaworek

Dermatology Review · 2026 · 113 (2) · 102-106

DOI: 10.5114/dr.2026.163240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology Review, 2026. Verfasst von Anna Wojas-Pelc und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wojas-Pelc, A., Brzozowska, M., Kozłowska, A., Hałubiec, P., Obtułowicz, B., & Jaworek, A. K. (2026). Rituximab in Severe Mucocutaneous Pemphigus Vulgaris Complicated by Sepsis: a Difficult Path to Disease Control. Dermatology Review, 113(2), 102-106. https://doi.org/10.5114/dr.2026.163240

Vancouver

Wojas-Pelc A, Brzozowska M, Kozłowska A, Hałubiec P, Obtułowicz B, Jaworek AK. Rituximab in Severe Mucocutaneous Pemphigus Vulgaris Complicated by Sepsis: a Difficult Path to Disease Control. Dermatology Review. 2026;113(2):102-106. doi:10.5114/dr.2026.163240

BibTeX
@article{WojasPelc2026,
  author = {Wojas-Pelc, Anna and Brzozowska, Mirella and Kozłowska, Arletta and Hałubiec, Przemysław and Obtułowicz, Bartosz and Jaworek, Andrzej K.},
  title = {Rituximab in Severe Mucocutaneous Pemphigus Vulgaris Complicated by Sepsis: a Difficult Path to Disease Control},
  journal = {Dermatology Review},
  year = {2026},
  volume = {113},
  number = {2},
  pages = {102--106},
  doi = {10.5114/dr.2026.163240}
}
Kostenlos starten →